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Abstract
Background: The relationship between Human Papillomavirus (HPV) infection and conjunctiva cancer is
controversial. HPV detection will provide more information about the role of this infectious agent in the biology of
conjunctiva cancer. In the present study, DNA extracted and purified from 36 Conjunctival Squamous Cell
Carcinomas (CSCC) was evaluated by PCR for HPV DNA sequences. The results were correlated with the clinical and
histopathological variables.
Results: The results showed that HPV DNA was present in 8 CSCC samples (22%); HPV16 was the sole type
detected. Significant association was found between HPV detection and the limbus tumor subtype (p = 0.03). All
the samples were non-metastatic squamous cell carcinoma.
Conclusions: The HPV presence in CSCC from Mexican patients is not a common event.
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Background
Squamous cell carcinoma (SCC) is the most common
neoplasm of the conjunctiva [1]. The etiology of cancer
of the conjunctiva appears to be multifactorial; several
risk factors have been identified, such as smoke, Human
immunodeficiency virus (HIV) infection, Ultraviolet
(UV) light, history of pterygium, or Human papilloma-
virus infection (HPV) [2,3]. However, the reports on
HPV and conjunctival neoplasms are controversial.
Some studies have reported a heterogeneous prevalence
of high-risk HPV types, suggesting that only a subset of
cases can be attributed to these viruses [4,5]. Differences
in detection methods, populations, or geographic distri-
bution could contribute to the variation in HPV infec-
tion rates in Conjunctival Squamous Cell Carcinoma
(SCC)[6-12]. HPV is considered the main etiologic agent
in proliferative ocular surface, lachrymal sac lesions, and
pterygium worldwide, and it is has been suggested that
HPV types 16 and 18 play a critical role in the oncogen-
esis of conjunctival cancers [13-17].
HPV are a group of host-specific DNA viruses with
oncogenic subtypes that have been shown to act as car-
cinogens in the development of Cervical Cancer (CC),
anogenital, head and neck, and CSCC [18,19]. While the
E6 oncoprotein, encoded by HPV16 or HPV18, is
known to bind the cancer gene product p53 and to pro-
mote its degradation, the E7 oncoprotein binds to the
retinoblastoma cancer gene product pRB and results in
E7-induced pRB inactivation. The E5 virus protein coop-
erates with E7 to transform cells and enhances the abil-
i t yo fE 7t oi n d u c ep r o l i f e r a t i o n ,a n dw i t hE 6 ,t o
immortalize cells [20]. Preclinical and clinical studies
suggest that the adoption of HPV vaccination strategies
may exert an impact on the incidence of CC and poten-
tially on other HPV infection-associated cancers, such as
conjunctival cancer [21].
In order to elucidate the presence of HPV in CSCC, in
the present study a group of fixed and paraffin-
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were analyzed, and a systematic review of the literature
was performed.
Results
Prevalence of HPV Infection in Conjunctival Carcinoma
Worldwide
The PubMed database (National Library of Medicine,
Bethesda, MD, USA) was used to identify all of the arti-
cles published between 1986 and August 2011 contain-
ing combinations of the Medical Subject Headings
“Human papillomavirus” and “Conjunctival carcinoma”.
All articles reporting data of HPV prevalence in con-
junctival carcinomas were selected and reviewed (45
reports). To have a more robust analysis, publications
containing < 10 studied cases were excluded from the
analysis. Finally, 21 articles were included in this review.
Information on country of origin, year, authors, sample
size, and mucosal and cutaneous HPV prevalence was
retrieved (Table 1).
Detection of HPV Sequences in Conjunctival Carcinomas
of Mexican Patients
To demonstrate the quality of the DNA for amplifica-
tion reaction, DNA purified from formalin-fixed tissue
samples was first subjected to PCR utilizing D-loop
mitochondrial primers. This amplicon was consistent in
all cases (Figure 1). Therefore, DNA was analyzed for
the presence of HPV16/E6 (primers yielding a 126 bp
fragment). These primer sets allowed detection of HPV
DNA in 22% of the CSCC samples (8/36). Even when
excessive DNA fragmentation was due to the tissue fixa-
tion process, our results might be considered as valid in
showing the prevalence of HPV in the CSCC analyzed.
In general, HPV16 was the sole type detected in CSCC
samples (8/36, 22%). HPV type was confirmed by DNA
sequencing (data not shown).
Table 1 Geographic distribution of Human Papillomavirus in conjunctiva carcinoma
Continent Authors Year N cases HPV cutaneous prevalence HPV mucosal prevalence Countries
African Yu JJ 2010 11 0 9 (81%) Uganda, Kenya
Ateenyi-Agaba C 2010 94 42 (44.7%) 6 (6.4%) Uganda
DeKoning MN 2008 24 10 (42%) 3 (13%) Uganda
Tornesello ML 2006 29 3 (10.3%) 0 Uganda
Moubayeb P 2004 14 0 5 (35%) Tanzania
Ateenyi-Agaba C 2004 21 0 18 (86%) Uganda
Newton R 2002 39 0 11 (28%) Uganda
Waddell KM 1996 20 0 7 (35%) Uganda, Malawi
Europe Reszec J 2010 38 0 2 (5.2%) Poland
Guthoff R 2009 31 0 0 Germany
Reszec J 2005 11 0 1 (9%) Poland
Toth J 2000 23 0 5 (22%) Hungary
Asia Manderwad GP 2009 48 0 0 India
Sen S 2007 30 0 0 India
Jung SM 2006 13 0 0 Taiwan
Tulvatana W 2002 30 0 0 Thailand
Eng HL 2002 20 0 0 China
Karcioglu ZA 1997 31 0 17 (55%) Saudi Arabia
Oceania Tabrizi SN 1997 88 0 34 (39%) Australia
America Palazzi MA 2000 31 0 4 (12%) Brazil
McDonell JM 1992 11 0 7 (63%) USA
Present work 2011 36 0 8 (22%) Mexico
Publications containing less than ten cases studied were excluded from the analysis. In total were 21 reports covering more than 650 cases with an average of
28% in 15 countries. A range from 0-86% was observed
Figure 1 Illustrative example of PCR reaction for the HPV16/E6
region and D-loop mitochondrial region in conjunctival
carcinoma samples. Lanes 1, 2, 3 and 6 correspond to positive
HPV16 samples (126 bp); lanes 4 and 5 correspond to negative
HPV16 samples; all the samples were positive to mitochondrial
region amplification (150 bp). Positive HPV16 (Caski) and negative
HPV (C33) controls were included. MW: molecular weight marker
100 bp.
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Clinicopathological Variables
The age of patients ranged from 24-92 years, with a
mean age of 66 years. Distribution by age group was as
follows: 25% (n = 9), > 80 years of age; 61% (n = 22),
aged between 50 and 79 years, and only 14% (n =5 )
were < 49 years of age. Patients positive or negative to
HPV infection were stratified by age group (Table 2).
Anatomical analysis showed that in CSCC, limbus type
was 58% (21/36), followed by conjunctival type, 42%
(Table 2). None of the patients had a previous history of
pterygium. Sexual transmitted diseases (STD) history
was not considered because the STD data provided was
not considered accurate. Significant association was
found between HPV detection and limbus subtype (p <
0.05), but no statistically significant correlation between
HPV and differentiation degree was found (p > 0.05)
(Table 2).
Discussion
Development of CSCC such as cervical cancer could be
strongly linked with infection by high-risk HPV types
[22]. There is molecular evidence that viral oncoproteins
E6 and E7, found in high-risk HPV genotypes that are
inactive cancer genes p53 and pRb, promote genomic
rearrangement and confer replicative and immortalizing
activities on cervical neoplasms and other cancers [20].
According to the model of cervical carcinogenesis,
which assigns HPV infection a central initiating role,
identical or similar mechanisms could be responsible for
the development of conjunctival cancer.
In reviewing the literature on CSCC and its relation-
ship with HPV, it is evident that a major discrepancy
exists among the reports published. Intriguingly, in pub-
lished data on HPV DNA analysis in conjunctival carci-
noma, < < 1,000 samples were studied in nearly 21
reports, showing serious differences. Based on the pre-
sent study and certain other reports that failed to
demonstrate the HPV DNA of any HPV (mucosal or
not), as in studies in Taiwan, Thailand, China, India, or
Germany, we tend to conclude that HPV is highly, but
not conclusively, unlikely to play any causal role in the
pathogenesis of conjunctival cancer [6,8,13,15,23-25].
Even when HIV infection could act as an important risk
factor for conjunctival cancer, reports showing a high
percentage of HPV DNA sequences in CSCC HIV+
could indicate a biased result with respect to HPV fre-
quencies [4,26].
It is noteworthy that Mexico is a country with a high
incidence of CC [27]; however, in the present work we
show a low percentage of mucosal HPV sequences,
mainly HPV 16 (22%) in conjunctival carcinoma. Inter-
estingly, limbus tumor was found related with the pre-
sence of HPV; this association could be explained
because limbus tissue is quite similar in concept to that
of transitional epithelium, as in cervical epithelium. The
low frequency of HPV DNA in conjunctival cancer in
our Mexican population failed to support HPV as a rele-
vant etiological factor for this tumor type. Additional
studies will be required prior to there being a definitive
relationship between HPV and conjunctival cancer.
Methods
Tissues and DNA extraction
We analyzed 36 CSCC formalin-fixed paraffin-
embedded specimens for HPV DNA detection. The
samples were collected (during 2004-2008) from the
Department of Pathology archives of the Hospital de la
Luz, S.S., at Mexico City. All patients were subjected to
surgery. All the samples consisted of the invasive con-
junctiva squamous cell carcinoma. At present, the
patients abandoned the clinical assistance, because they
were free-disease. A tissue section of each specimen was
hematoxilin and eosin stained and blindly analyzed by
two independent pathologists to confirm the diagnosis.
Information of clinical variables such as age, gender,
sexually transmitted diseases, subtype clinical, histologi-
cal differentiation and pterygium history were collected;
in some cases the information were not available. Two
10 μm non-stained tissue sections were mounted on
clean slides deparaffinized and rehydrated by standard
methods. To avoid false negatives, defined tumor areas
were manually microdissected under the light micro-
scope (20× objective) with an sterilized needle, the
scrapped tissue was then collected in a microtube con-
taining 500 μl of digestion buffer (100 mM NaCl, 10
mM Tris-Cl pH 8, 25 mM EDTA pH 8, 0.5% SDS, and
Table 2 Correlation between HPV detection and
clinicopathological variables in conjunctival cancer
samples
Clinicopathological
variables
HPV
N Positive Negative P value
All cases 36 8 28
Age 0.36
≤ 50 9 3 6
>5 0 2 7 5 2 2
Gender 0.84
Male 26 6 20
Female 10 2 8
Subtype Clinical 0.03*
Limbus 21 2 19
Conjunctive 15 6 9
Histological differentiation 0.49
Well 10 3 7
Moderate/Poor 26 5 21
HPV: human papillomavirus presence. * Statistical significance
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Page 3 of 50.1 mg/ml proteinase K), and incubated at 55°C for 48
hours. The DNA was extracted by means of Wizard
Extraction kit (Promega, Madison WI, USA) according
to manufacturers.
HPV detection and typing
The presence of HPV DNA was determined by PCR ana-
lysis with consensus primers HPV16/E6 [28], which
amplify, a fragment of E6 gene of 126 bp of HPV16. The
PCR solution contained: 200 ng of tumor DNA, 1× buffer
(50 mM KCl, 10 mM Tris- HCl, 0.1% Triton X-100), 2
mM MgCl2, 0.2 mM of each dNTP, 50 pmol of each pri-
mer and 2 units of Taq DNA polymerase (Promega) in
50 μl of final volume. The reaction tubes were placed in a
thermal cycler (MJ Research Minicycler) with the follow-
ing program: one cycle of denaturing at 94°C for 30 sec,
and 40 cycles of denaturation at 94°C for 4 min, anneal-
ing at 55°C for 1.5 min, and extension at 72°C for 1.5
min, with a final extension at 72°C for 1.5 min. CaSKi
DNA (HPV16+) was used as a positive control, C33
(HPV-), and lymphocyte DNA were included as negative
controls. Before HPV detection, primers for human D-
loop mitochondrial region genes were used as internal
controls to monitoring DNA quality.
Statistical analysis
All comparisons for significance were performed by
means Χ
2-test. All p values represent two-tailed test and
were considered significant at 0.05. The statistical analy-
sis was performed using the SPSS v15 statistical
software.
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